<DOC>
	<DOCNO>NCT00080145</DOCNO>
	<brief_summary>This 24-week study compare safety effectiveness medication treatment alone ( risperidone aripiprazole ) medication treatment combination parent management training program .</brief_summary>
	<brief_title>RUPP PI PDD : Drug Behavioral Therapy Children With Pervasive Developmental Disorders</brief_title>
	<detailed_description>PDD profoundly disable condition across social , emotional , academic domain . Safe effective treatment PDD need . Participants randomly assign receive either risperidone plus parent management train risperidone alone 24 week . Participants show deterioration Week 4 offer alternative mediation treatment , aripiprazole . These participant remain original treatment group ( either med alone med plus parent management training ) . After 6 month treatment ( Week 24 ) , participant respond treatment gradually discontinue medication treatment learn response sustain without continued medication treatment ( This phase study end Nov. 2006 ) Adaptive behavioral outcome assess study .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Developmental Disabilities</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Autistic Disorder , Asperger 's Disorder , Pervasive Developmental Disorder otherwise specify Weight &gt; 30 lb IQ &gt; = 35 mental age least 18 month Psychotic Disorder History intolerance nonresponse risperidone Pregnancy History neuroleptic malignant syndrome</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Autistic Disorder</keyword>
	<keyword>Asperger Syndrome</keyword>
</DOC>